loadpatents
name:-0.047807931900024
name:-0.017133951187134
name:-0.0011460781097412
Tomai; Mark A. Patent Filings

Tomai; Mark A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tomai; Mark A..The latest application filed is for "individualized medicine using causal models".

Company Profile
0.15.28
  • Tomai; Mark A. - Hudson WI
  • TOMAI; MARK A. - WOODBURY MN
  • Tomai, Mark A. - Oakdale MN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Individualized Medicine Using Causal Models
App 20220189632 - Brooks; Brian E. ;   et al.
2022-06-16
Manufacturing A Biologic Pharmaceutical Using Causal Models
App 20220178899 - Brooks; Brian E. ;   et al.
2022-06-09
Adaptive Clinical Trials
App 20220180979 - Brooks; Brian E. ;   et al.
2022-06-09
Controlling Hospital Operations Using Causal Models
App 20220172830 - Brooks; Brian E. ;   et al.
2022-06-02
Treatment For Cutaneous T Cell Lymphoma
App 20170340612 - ROOK; ALAIN H. ;   et al.
2017-11-30
Methods And Compositions For Enhancing Immune Response
App 20170319712 - MILLER; RICHARD L. ;   et al.
2017-11-09
Methods and compositions for enhancing immune response
Grant 9,801,947 - Miller , et al. October 31, 2
2017-10-31
Therapeutic Combinations And Methods Including Irm Compounds
App 20150110784 - Tomai; Mark A. ;   et al.
2015-04-23
Methods And Compositions For Enhancing Immune Response
App 20150044279 - Miller; Richard L. ;   et al.
2015-02-12
Therapeutic combinations and methods including IRM compounds
Grant 8,940,755 - Tomai , et al. January 27, 2
2015-01-27
Treatment For Cutaneous T Cell Lymphoma
App 20090246174 - Rook; Alain H. ;   et al.
2009-10-01
Methods for the treatment of periodontal disease
Grant 7,226,928 - Mitra , et al. June 5, 2
2007-06-05
Screening method for identifying compounds that selectively induce interferon alpha
App 20060009482 - Tomai; Mark A. ;   et al.
2006-01-12
Methods and compositions related to IRM compounds and toll-like receptor pathways
App 20050245564 - Gorden, Keith B. ;   et al.
2005-11-03
Enhancement of immune responses
App 20050239735 - Miller, Richard L. ;   et al.
2005-10-27
Therapeutic combinations and methods including IRM compounds
App 20050226878 - Tomai, Mark A. ;   et al.
2005-10-13
Therapeutic combinations and methods including IRM compounds
App 20050171072 - Tomai, Mark A. ;   et al.
2005-08-04
Immunomodulatory combinations
App 20050158325 - Hammerbeck, David M. ;   et al.
2005-07-21
Dye labeled imidazoquinoline compounds
Grant 6,916,925 - Rice , et al. July 12, 2
2005-07-12
Neutrophil activation by immune response modifier compounds
App 20050096259 - Tomai, Mark A. ;   et al.
2005-05-05
Immunostimulatory combinations and treatments
App 20050048072 - Kedl, Ross M. ;   et al.
2005-03-03
Methods and compositions for enhancing immune response
App 20040265351 - Miller, Richard L. ;   et al.
2004-12-30
Immune response modifier compounds for treatment of TH2 mediated and related diseases
App 20040242620 - Tomai, Mark A. ;   et al.
2004-12-02
Immune response modifiers for the treatment of periodontal disease
App 20040235881 - Mitra, Sumita B. ;   et al.
2004-11-25
Immune response modifier compounds for treatment of TH2 mediated and related diseases
Grant 6,696,076 - Tomai , et al. February 24, 2
2004-02-24
Methods and compositions related to IRM compounds and toll-like recptor pathways
App 20040014779 - Gorden, Keith B. ;   et al.
2004-01-22
Immune Response Modifier Compounds For Treatment Of Th2 Mediated And Related Diseases
App 20030206868 - Tomai, Mark A. ;   et al.
2003-11-06
Dye labeled imidazoquinoline compounds
Grant 6,630,588 - Rice , et al. October 7, 2
2003-10-07
Maturation of dendritic cells with immune response modifying compounds
App 20030186440 - Tomai, Mark A. ;   et al.
2003-10-02
Immune response modifier compounds for treatment of TH2 mediated and related diseases
Grant 6,610,319 - Tomai , et al. August 26, 2
2003-08-26
Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
App 20030133913 - Tomai, Mark A. ;   et al.
2003-07-17
Maturation of dendritic cells with immune response modifying compounds
Grant 6,558,951 - Tomai , et al. May 6, 2
2003-05-06
Dye labeled imidazoquinoline compounds
App 20020120141 - Rice, Michael J. ;   et al.
2002-08-29
Screening method for identifying compounds that selectively induce interferon alpha
App 20020110840 - Tomai, Mark A. ;   et al.
2002-08-15
Dye labeled imidazoquinoline compounds
Grant 6,376,669 - Rice , et al. April 23, 2
2002-04-23
Immune response modifier compounds for treatment of TH2 mediated and related diseases
App 20020041887 - Tomai, Mark A. ;   et al.
2002-04-11
Gel formulations for topical drug delivery
Grant 6,365,166 - Beaurline , et al. April 2, 2
2002-04-02
Gel Formulations For Topical Drug Delivery
App 20020015715 - BEAURLINE, JOSEPH M. ;   et al.
2002-02-07
Immine response modifier compounds for treatment of TH2 mediated and related diseases
Grant 6,200,592 - Tomai , et al. March 13, 2
2001-03-13
1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants
Grant 6,083,505 - Miller , et al. July 4, 2
2000-07-04
Immune response modifier compounds for treatment of TH2 mediated and related diseases
Grant 6,039,969 - Tomai , et al. March 21, 2
2000-03-21
Gel formulations for topical drug delivery
Grant 5,939,090 - Beaurline , et al. August 17, 1
1999-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed